Characterization of transgene expression in adenoviral vector-based HIV-1 vaccine candidates

Recombinant adenovirus vectors have been extensively used in gene therapy clinical studies. More recently, the capability of inducing potent cell-mediated and humoral immunity has made these vectors equally attractive candidates for prophylactic or therapeutic vaccine applications. Merck and Co., In...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Marie-Noëlle, Rolling, Judith A, Owen, Katherine E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828417/
https://www.ncbi.nlm.nih.gov/pubmed/20163742
http://dx.doi.org/10.1186/1743-422X-7-39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828417/
https://www.ncbi.nlm.nih.gov/pubmed/20163742
http://dx.doi.org/10.1186/1743-422X-7-39

Ejemplares similares